Emerging Mutation-Targeted Therapies Aim to Reduce the Global NSCLC...

bir ses eklendi Health

2025-12-29 20:14:29 -

Emerging Mutation-Targeted Therapies Aim to Reduce the Global NSCLC Burden

Non-small cell lung cancer (NSCLC) continues to be a leading cause of cancer-related death globally, accounting for approximately 85% of all lung cancer cases. The growing metastatic nsclc epidemiology highlights the substantial clinical and economic challenges associated with late-stage diagnosis and limited long-term survival. Recent advancements in molecular oncology, particularly...

0 Yorumlar 0 hisse senetleri 408 Views 0 önizleme